RS
R Squared Portfolio holdings
AUM
$181M
This Quarter Return
+0.01%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$103M
AUM Growth
–
Cap. Flow
+$103M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
10.53%
Holding
1,571
New
1,571
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Linde
LIN
|
$2.38M |
| 2 |
FirstEnergy
FE
|
$1.14M |
| 3 |
Eaton
ETN
|
$1.02M |
| 4 |
Consolidated Edison
ED
|
$964K |
| 5 |
Verizon
VZ
|
$951K |
Top Sells
No sells this quarter
Sector Composition
| 1 | Financials | 18.63% |
| 2 | Technology | 14.63% |
| 3 | Industrials | 13.87% |
| 4 | Consumer Discretionary | 12.94% |
| 5 | Healthcare | 11.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1426
Green Plains
GPRE
$665M
| $2.75K | ﹤0.01% |
+290
| New | +$2.75K |
|
1427
HarborOne Bancorp
HONE
$562M
| $2.72K | ﹤0.01% |
+230
| New | +$2.72K |
|
1428
Ormat Technologies
ORA
$5.48B
| $2.71K | ﹤0.01% |
+40
| New | +$2.71K |
|
1429
Inogen
INGN
$224M
| $2.66K | ﹤0.01% |
+290
| New | +$2.66K |
|
|
UPB
1430
Upstream Bio, Inc. Common Stock
UPB
$1.02B
| $2.63K | ﹤0.01% |
+160
| New | +$2.63K |
|
1431
Nature's Sunshine
NATR
$302M
| $2.62K | ﹤0.01% |
+179
| New | +$2.62K |
|
1432
MACOM Technology Solutions
MTSI
$9.73B
| $2.6K | ﹤0.01% |
+20
| New | +$2.6K |
|
1433
Dorman Products
DORM
$5.07B
| $2.59K | ﹤0.01% |
+20
| New | +$2.59K |
|
1434
Q32 Bio
QTTB
$21.3M
| $2.58K | ﹤0.01% |
+750
| New | +$2.58K |
|
1435
OR Royalties Inc.
OR
$6.58B
| $2.53K | ﹤0.01% |
+140
| New | +$2.53K |
|
1436
Merus
MRUS
$5.05B
| $2.52K | ﹤0.01% |
+60
| New | +$2.52K |
|
1437
AerSale
ASLE
$396M
| $2.52K | ﹤0.01% |
+400
| New | +$2.52K |
|
|
BCYC
1438
Bicycle Therapeutics
BCYC
$482M
| $2.52K | ﹤0.01% |
+180
| New | +$2.52K |
|
|
PPBI
1439
DELISTED
Pacific Premier Bancorp
PPBI
| $2.49K | ﹤0.01% |
+100
| New | +$2.49K |
|
|
DMN
1440
DELISTED
Damon Inc. Common Stock
DMN
| $2.47K | ﹤0.01% |
+2,910
| New | +$2.47K |
|
1441
Greenfire Resources
GFR
$357M
| $2.4K | ﹤0.01% |
+340
| New | +$2.4K |
|
|
CLYM
1442
Climb Bio, Inc. Common Stock
CLYM
$168M
| $2.39K | ﹤0.01% |
+1,330
| New | +$2.39K |
|
1443
Trade Desk
TTD
$25.2B
| $2.35K | ﹤0.01% |
+20
| New | +$2.35K |
|
1444
Allbirds
BIRD
$52M
| $2.31K | ﹤0.01% |
+332
| New | +$2.31K |
|
1445
SELLAS Life Sciences
SLS
$200M
| $2.29K | ﹤0.01% |
+2,197
| New | +$2.29K |
|
1446
Capital Bancorp
CBNK
$561M
| $2.28K | ﹤0.01% |
+80
| New | +$2.28K |
|
1447
ODP
ODP
$639M
| $2.27K | ﹤0.01% |
+100
| New | +$2.27K |
|
|
IGMS
1448
DELISTED
IGM Biosciences
IGMS
| $2.26K | ﹤0.01% |
+370
| New | +$2.26K |
|
1449
Lexicon Pharmaceuticals
LXRX
$389M
| $2.25K | ﹤0.01% |
+3,040
| New | +$2.25K |
|
1450
Zurn Elkay Water Solutions
ZWS
$7.79B
| $2.24K | ﹤0.01% |
+60
| New | +$2.24K |
|